{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:20:16Z","timestamp":1779186016050,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s13365-015-0340-4","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T13:56:04Z","timestamp":1430142964000},"page":"694-701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine"],"prefix":"10.1007","volume":"21","author":[{"given":"Rebekka","family":"Kurmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Weisstanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Kardas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans H.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"L\u00e4mmle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansjakob","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"Du Pasquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio L.","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Sturzenegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Krestel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,28]]},"reference":[{"key":"340_CR1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamaneurol.2014.825","volume":"71","author":"KB Alstadhaug","year":"2014","unstructured":"Alstadhaug KB, Croughs T, Henriksen S et al (2014) Treatment of progressive multifocal leukoencephalopathy with interleukin 7. JAMA Neurol 71:1030\u20131035","journal-title":"JAMA Neurol"},{"key":"340_CR2","first-page":"839719","volume":"10","author":"A Bellizzi","year":"2013","unstructured":"Bellizzi A, Anzivino E, Rodio DM et al (2013) New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy. Clin Dev Immunol 10:839719","journal-title":"Clin Dev Immunol"},{"key":"340_CR3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2169\/internalmedicine.51.6810","volume":"51","author":"M Beppu","year":"2012","unstructured":"Beppu M, Kawamoto M, Nukuzuma S et al (2012) Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med 51:1245\u20131247","journal-title":"Intern Med"},{"key":"340_CR4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB et al (2013) PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 80:1430\u20131438","journal-title":"Neurology"},{"key":"340_CR5","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01614-08","volume":"53","author":"M Brickelmaier","year":"2009","unstructured":"Brickelmaier M, Lugovskoy A, Kartikeyan R et al (2009) Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53:1840\u20131849","journal-title":"Antimicrob Agents Chemother"},{"key":"340_CR6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archneurol.2008.557","volume":"66","author":"D Cettomai","year":"2009","unstructured":"Cettomai D, McArthur JC (2009) Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol 66:255\u2013258","journal-title":"Arch Neurol"},{"key":"340_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2013.01.010","volume":"326","author":"PG Christakis","year":"2013","unstructured":"Christakis PG, Okin D, Huttner AJ et al (2013) Progressive multifocal leukoencephalopathy in an immunocompetent patient. J Neurol Sci 326:107\u2013110","journal-title":"J Neurol Sci"},{"key":"340_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13365-013-0173-y","volume":"19","author":"DB Clifford","year":"2013","unstructured":"Clifford DB, Nath A, Cinque P et al (2013) A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. J Neurovirol 19:351\u2013358","journal-title":"J Neurovirol"},{"key":"340_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2013.02.002","volume":"327","author":"M Delgado-Alvarado","year":"2013","unstructured":"Delgado-Alvarado M, Sedano MJ, Gonz\u00e1lez-Quintanilla V et al (2013) Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia. J Neurol Sci 327:75\u201379","journal-title":"J Neurol Sci"},{"key":"340_CR10","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"GF Elphick","year":"2004","unstructured":"Elphick GF, Querbes W, Jordan JA et al (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380\u20131383","journal-title":"Science"},{"key":"340_CR11","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1128\/JVI.02506-10","volume":"85","author":"S Gheuens","year":"2011","unstructured":"Gheuens S, Bord E, Kesari S et al (2011) Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 85:7256\u20137263","journal-title":"J Virol"},{"key":"340_CR12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/apm.12128","volume":"121","author":"H Hirsch","year":"2013","unstructured":"Hirsch H, Kardas P, Kranz D et al (2013) The human polyomavirus (JCPyV): virological background and clinical implications. Acta Pathol Microbiol Immunol Scand 121:685\u2013727","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"340_CR13","doi-asserted-by":"crossref","unstructured":"Hohlfeld SK, G\u00fcnthard HF, Zeitz J et al (2012) Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis. BMJ Case Rep. doi: 10.1136\/bcr.03.2011.4036","DOI":"10.1136\/bcr.03.2011.4036"},{"key":"340_CR14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13365-013-0167-9","volume":"19","author":"M Iannetta","year":"2013","unstructured":"Iannetta M, Bellizzi A, Lo Menzo S et al (2013) HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity. J Neurovirol 19:274\u2013279","journal-title":"J Neurovirol"},{"key":"340_CR15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/ajt.12153","volume":"13","author":"RY Loyaga-Rendon","year":"2013","unstructured":"Loyaga-Rendon RY, Taylor DO, Koval CE (2013) Progressive multifocal leukoencephalopathy in a heart transplant recipient following rituximab therapy for antibody-mediated rejection. Am J Transplant 13:1075\u20131079","journal-title":"Am J Transplant"},{"key":"340_CR16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/606059","volume":"49","author":"M Malphettes","year":"2009","unstructured":"Malphettes M, G\u00e9rard L, Carmagnat M et al (2009) Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 49:1329\u20131338","journal-title":"Clin Infect Dis"},{"key":"340_CR17","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1128\/JCM.43.8.4175-4177.2005","volume":"43","author":"A Marzocchetti","year":"2005","unstructured":"Marzocchetti A, Di Giambenedetto S, Cingolani A et al (2005) Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol 43:4175\u20134177","journal-title":"J Clin Microbiol"},{"key":"340_CR18","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/WNL.0b013e3181c0d4a1","volume":"73","author":"A Marzocchetti","year":"2009","unstructured":"Marzocchetti A, Tompkins T, Clifford DB et al (2009) Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 73:1551\u20131558","journal-title":"Neurology"},{"key":"340_CR19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5014\/ajot.39.6.386","volume":"39","author":"V Mathiowetz","year":"1985","unstructured":"Mathiowetz V, Volland G, Kashman N et al (1985) Adult norms for the box and block test of manual dexterity. Am J Occup Ther 39:386\u2013391","journal-title":"Am J Occup Ther"},{"key":"340_CR20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2146\/ajhp110392","volume":"69","author":"RP Moenster","year":"2012","unstructured":"Moenster RP, Jett RA (2012) Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus. Am J Health Syst Pharm 69:496\u2013498","journal-title":"Am J Health Syst Pharm"},{"key":"340_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2169\/internalmedicine.51.6253","volume":"51","author":"K Naito","year":"2012","unstructured":"Naito K, Ueno H, Sekine M et al (2012) Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI Study. Intern Med 51:205\u2013209","journal-title":"Intern Med"},{"key":"340_CR22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.5014\/ajot.57.5.570","volume":"57","author":"K Oxford Grice","year":"2003","unstructured":"Oxford Grice K, Vogel KA, Le V et al (2003) Adult norms for a commercially available nine hole peg test for finger dexterity. Am J Occup Ther 57:570\u2013573","journal-title":"Am J Occup Ther"},{"key":"340_CR23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075199","volume":"8","author":"D Paquin-Proulx","year":"2013","unstructured":"Paquin-Proulx D, Santos BA, Carvalho KI et al (2013) IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID. PLoS ONE 8, e75199","journal-title":"PLoS ONE"},{"key":"340_CR24","first-page":"1584","volume":"105","author":"P Roth","year":"1975","unstructured":"Roth P, Morell A, Hunziker HR et al (1975) Schweiz med Wschr 105:1584\u20131585","journal-title":"Schweiz med Wschr"},{"key":"340_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar4032","volume":"14","author":"U Salzer","year":"2012","unstructured":"Salzer U, Warnatz K, Peter HH (2012) Common variable immunodeficiency\u2014an update. Arthritis Res Ther 14:223","journal-title":"Arthritis Res Ther"},{"key":"340_CR26","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archneurol.2010.157","volume":"67","author":"A Schr\u00f6der","year":"2010","unstructured":"Schr\u00f6der A, Lee DH, Hellwig K et al (2010) Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol 67:1391\u20131394","journal-title":"Arch Neurol"},{"key":"340_CR27","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1016\/j.ijid.2009.06.005","volume":"14","author":"G Squintani","year":"2010","unstructured":"Squintani G, Ferrari S, Bazzoli E et al (2010) Progressive multifocal leukoencephalopathy in a patient with Good\u2019s syndrome. Int J Infect Dis 14:e444\u2013e447","journal-title":"Int J Infect Dis"},{"key":"340_CR28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s11910-012-0313-4","volume":"12","author":"I Steiner","year":"2012","unstructured":"Steiner I, Berger JR (2012) Update on progressive multifocal leukoencephalopathy. Curr Neurol Neurosci Rep 12:680\u2013686","journal-title":"Curr Neurol Neurosci Rep"},{"key":"340_CR29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1086\/520514","volume":"196","author":"S Verma","year":"2007","unstructured":"Verma S, Cikurel K, Koralnik IJ et al (2007) Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis 196:709\u2013711","journal-title":"J Infect Dis"},{"key":"340_CR30","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/jnnp.2006.092353","volume":"77","author":"S Vulliemoz","year":"2006","unstructured":"Vulliemoz S, Lurati-Ruiz F, Borruat FX et al (2006) Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry 77:1079\u20131082","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"340_CR31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ncl.2008.03.007","volume":"26","author":"T Weber","year":"2008","unstructured":"Weber T (2008) Progressive multifocal leukoencephalopathy. Neurol Clin 26:833\u2013854","journal-title":"Neurol Clin"},{"key":"340_CR32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/NEN.0b013e31823ede59","volume":"71","author":"C W\u00fcthrich","year":"2012","unstructured":"W\u00fcthrich C, Koralnik IJ (2012) Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 71:54\u201365","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-015-0340-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-015-0340-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-015-0340-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T16:08:34Z","timestamp":1559491714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-015-0340-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,28]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["340"],"URL":"https:\/\/doi.org\/10.1007\/s13365-015-0340-4","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,28]]}}}